Home/Filings/4/0000950142-23-001814
4//SEC Filing

GAP (Bermuda) L.P. 4

Accession 0000950142-23-001814

CIK 0001847903other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 7:03 PM ET

Size

23.3 KB

Accession

0000950142-23-001814

Insider Transaction Report

Form 4
Period: 2023-06-22
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Transactions
  • Award

    Share Option (right to buy)

    2023-06-22+48,00048,000 total(indirect: See footnote)
    Exercise: $6.35Exp: 2023-06-22Ordinary Shares (48,000 underlying)
Footnotes (4)
  • [F1]The Ordinary Shares subject to the Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to Dr. Brett Zbar's continued service as a director of the Issuer through the applicable vesting date.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F3]The Share Option was granted to Dr. Zbar who is an employee of General Atlantic Service Company, L.P., a Delaware limited partnership ("GASC ") and director of the Issuer.
  • [F4]The Share Option granted to Dr. Zbar is held by him solely for the benefit of GASC, which is controlled by the management committee of GASC MGP, LLC (the "Management Committee"). There are eleven members of the Management Committee. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother
IncorporatedBermuda

Related Parties

1
  • filerCIK 0001406817

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 7:03 PM ET
Size
23.3 KB